so, you know how sometimes when you're playing tag, you run really fast and then you stop suddenly and spin around to see if anyone's coming to tag you? well, stocks are a bit like that. they can move really fast and then stop suddenly, and people are always trying to figure out which way they're going to go next. one way people try to guess which way a stock will go is by looking at how quickly the price is changing, and if more people are buying or selling it. this is called momentum, and it's like trying to guess which way you'll go when you start running really fast in tag. another way people try to guess which way a stock will go is by looking at what experts think the stock's value will be in the future. this is called earnings estimate revisions, and it's like asking your friends what they think you'll be doing next in tag. if more friends agree with each other, it's easier to guess what you'll be doing next. so, this article is about a company called eli lilly, and how people think it's a good stock to invest in because it's moving really fast and lots of people are watching it. Read from source...

absent.

### Additional Insights:
- Eli Lilly is a great momentum stock with a Momentum Style Score of B, according to Zacks.
- The drugmaker's shares have risen 10.48% over the past quarter and 71.36% over the past year.
- Over the past two months, 10 earnings estimates for Eli Lilly have moved higher compared to one lower for the full year.

### Trading Strategy:
- Investors could consider buying shares of Eli Lilly, especially if they are looking for a solid momentum pick.
- As always, investors should do their own research and assess the risks before making any investment decision.

neutral

Sentiment Analysis:
The article discusses Eli Lilly as a great momentum stock, highlighting its recent price trend and earnings estimate revisions. While the company currently has a Zacks Rank of #2 (Buy) and a Momentum Style Score of B, the article emphasizes that momentum investing can be difficult to define and that following trends may not always lead to timely and profitable trades. The analysis is neutral, focusing on the potential for Eli Lilly to continue its upward trend without making any definitive claims or recommendations.

Always consult with a licensed financial advisor before making any investment decisions. Investing involves risks, including the loss of principal. Past performance is not indicative of future results. Always do your due diligence and research the companies and investments you are considering. This content should not be considered financial advice or a recommendation to buy or sell securities. It is intended to be general informational and educational purposes only.